• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

新型口服抗凝剂可用于冠状动脉瘤吗？

Could the Novel Oral Anticoagulants Be Used for Coronary Artery Aneurysm?

作者信息

Yan Quanxiang, Ning Libing, Jian Yu, Yang Wencong, Yuan Qinghua, Du Zhimin

机构信息

Cardiovasology, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China.

Department of Cardiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

出版信息

Case Rep Med. 2020 Apr 25;2020:5073814. doi: 10.1155/2020/5073814. eCollection 2020.

DOI:10.1155/2020/5073814
PMID:32373178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7196985/
Abstract

Coronary artery aneurysms (CAAs) are uncommon in coronary angiography, and left main coronary artery aneurysms are rare. There is no consensus for the treatment of CAAs. A young patient with left coronary artery aneurysm diagnosed by coronary angiography and with recurrent acute myocardial infarction was treated with rivaroxaban and aspirin. The patient had no angina for 6 months. Novel oral anticoagulants combined with antiplatelet agents may be appropriate for the treatment of CAAs.

摘要

冠状动脉瘤（CAAs）在冠状动脉造影中并不常见，而左主干冠状动脉瘤则更为罕见。目前对于CAAs的治疗尚无共识。一名通过冠状动脉造影诊断为左冠状动脉瘤且反复发生急性心肌梗死的年轻患者接受了利伐沙班和阿司匹林治疗。该患者6个月来未出现心绞痛。新型口服抗凝剂联合抗血小板药物可能适用于CAAs的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3410/7196985/ffec49726e09/CRIM2020-5073814.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3410/7196985/ffec49726e09/CRIM2020-5073814.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3410/7196985/ffec49726e09/CRIM2020-5073814.001.jpg

相似文献

1
Could the Novel Oral Anticoagulants Be Used for Coronary Artery Aneurysm?新型口服抗凝剂可用于冠状动脉瘤吗？
Case Rep Med. 2020 Apr 25;2020:5073814. doi: 10.1155/2020/5073814. eCollection 2020.
2
Congenital and Atherosclerotic (Acquired) Coronary Artery Aneurysms: Coronary Angiographic and Morphologic Observations in 10 Patients.
Int J Angiol. 1998 May;7(3):206-10. doi: 10.1007/BF01617394.
3
Multiple Giant Coronary Artery Aneurysms.多发性巨大冠状动脉瘤
Intern Med. 2017;56(15):1973-1976. doi: 10.2169/internalmedicine.56.8357. Epub 2017 Aug 1.
4
Saccular aneurysm and stenosis of the left anterior descending artery presenting with acute coronary syndrome. What is the best treatment: CABG or PCI?伴有急性冠脉综合征的左前降支囊状动脉瘤和狭窄。最佳治疗方案是什么：冠状动脉旁路移植术（CABG）还是经皮冠状动脉介入治疗（PCI）？
J Cardiol Cases. 2013 Aug 31;8(4):129-130. doi: 10.1016/j.jccase.2013.07.002. eCollection 2013 Oct.
5
Coronary Artery Aneurysms: A Review of the Epidemiology, Pathophysiology, Diagnosis, and Treatment.冠状动脉瘤：流行病学、病理生理学、诊断及治疗综述
Front Cardiovasc Med. 2017 May 5;4:24. doi: 10.3389/fcvm.2017.00024. eCollection 2017.
6
[Left main coronary artery aneurysm thrombosis in a young patient with acute myocardial infarction].
Cir Cir. 2013 Mar-Apr;81(2):138-42.
7
Antithrombotic Therapy of a Young Adult with Giant Left Main Coronary Artery Aneurysm.一名年轻成人巨大左冠状动脉瘤的抗栓治疗
Int Heart J. 2020 May 30;61(3):601-605. doi: 10.1536/ihj.19-451. Epub 2020 Apr 29.
8
Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome.抗 Xa 治疗降低急性冠状动脉综合征患者心血管事件的作用及标准治疗的附加作用（血栓溶解治疗急性心肌梗死 51 研究）的研究原理和设计：一项评估利伐沙班在急性冠状动脉综合征患者中的疗效和安全性的随机、双盲、安慰剂对照研究。
Am Heart J. 2011 May;161(5):815-821.e6. doi: 10.1016/j.ahj.2011.01.026.
9
Giant Right Coronary Artery Aneurysm Detected by Transthoracic Echocardiography.经胸超声心动图检测到巨大右冠状动脉瘤
J Cardiovasc Echogr. 2019 Jan-Mar;29(1):29-31. doi: 10.4103/jcecho.jcecho_59_18.
10
Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention after Acute Coronary Syndromes: a Review.直接口服抗凝剂联合抗血小板治疗用于急性冠状动脉综合征后的二级预防：综述。
Curr Cardiol Rep. 2019 Jan 28;21(1):5. doi: 10.1007/s11886-019-1088-x.

引用本文的文献

1
Coronary Artery Aneurysm Thrombosis in a Patient With Marfan Syndrome.马方综合征患者的冠状动脉瘤血栓形成
JACC Case Rep. 2024 Sep 18;29(18):102538. doi: 10.1016/j.jaccas.2024.102538.
2
Coronary Artery Ectasia: Case Reports and Literature Review.冠状动脉扩张：病例报告与文献综述
Cureus. 2024 Jun 9;16(6):e62011. doi: 10.7759/cureus.62011. eCollection 2024 Jun.
3
Two presentations of acute coronary syndrome with progression of giant right coronary artery aneurysm; a case report.急性冠状动脉综合征伴巨大右冠状动脉瘤进展的两种表现：一例报告

本文引用的文献

1
Coronary Artery Ectasia: An Insight into Intraprocedural and Postprocedural Management Strategies.冠状动脉扩张：对术中及术后管理策略的深入探讨
Cureus. 2019 Jan 21;11(1):e3928. doi: 10.7759/cureus.3928.
2
ST-Elevation Myocardial Infarction in Coronary Ectasia: A Case Report.冠状动脉扩张症合并ST段抬高型心肌梗死：一例报告
Diseases. 2018 Nov 16;6(4):104. doi: 10.3390/diseases6040104.
3
Left Main Coronary Artery Aneurysm.左冠状动脉动脉瘤
Eur Heart J Case Rep. 2022 Oct 31;6(11):ytac425. doi: 10.1093/ehjcr/ytac425. eCollection 2022 Nov.
4
Coronary Arteries Aneurysms: A Case-Based Literature Review.冠状动脉瘤：基于病例的文献综述。
Diagnostics (Basel). 2022 Oct 19;12(10):2534. doi: 10.3390/diagnostics12102534.
5
Thromboembolic ST elevation myocardial infarction due to a large coronary aneurysm: Role of apixaban.大型冠状动脉瘤所致血栓栓塞性ST段抬高型心肌梗死：阿哌沙班的作用
Anatol J Cardiol. 2021 Dec;25(12):922-923. doi: 10.5152/AnatolJCardiol.2021.128.
6
Percutaneous management strategies for STEMI with coexisting aneurysmal coronary- to-pulmonary artery fistula: a case report.
Eur Heart J Case Rep. 2021 May 16;5(5):ytab157. doi: 10.1093/ehjcr/ytab157. eCollection 2021 May.
N Engl J Med. 2018 Jun 7;378(23):e32. doi: 10.1056/NEJMicm1708877.
4
Coronary Artery Ectasia Predicts Future Cardiac Events in Patients With Acute Myocardial Infarction.冠状动脉扩张可预测急性心肌梗死患者未来的心脏事件。
Arterioscler Thromb Vasc Biol. 2017 Dec;37(12):2350-2355. doi: 10.1161/ATVBAHA.117.309683. Epub 2017 Oct 19.
5
Unexpected evolution of a non-stenotic lesion in the left main coronary artery of a patient with non-ST-segment elevation myocardial infarction.非ST段抬高型心肌梗死患者左主干冠状动脉非狭窄病变的意外演变。
Cardiovasc Diagn Ther. 2017 Jun;7(3):340-344. doi: 10.21037/cdt.2017.01.09.
6
An Unusual Cause of ST-Segment Elevation Myocardial Infarction.ST段抬高型心肌梗死的一种罕见病因
JACC Cardiovasc Interv. 2017 May 8;10(9):961-962. doi: 10.1016/j.jcin.2017.02.031. Epub 2017 Apr 12.
7
Mechanical and pharmacologic treatment in a patient with a coronary artery aneurysm and acute coronary syndrome.一名冠状动脉瘤合并急性冠状动脉综合征患者的机械及药物治疗
Coron Artery Dis. 2017 Jun;28(4):358-360. doi: 10.1097/MCA.0000000000000475.
8
Recurrent Acute Myocardial Infarction in a Patient with Severe Coronary Artery Ectasia: Implication of Antithrombotic Therapy.一名患有严重冠状动脉扩张症患者的复发性急性心肌梗死：抗栓治疗的意义
Am J Case Rep. 2016 Dec 12;17:939-943. doi: 10.12659/ajcr.900474.
9
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.达比加群、利伐沙班和阿哌沙班与华法林相比治疗非瓣膜性心房颤动的有效性和安全性。
J Am Heart Assoc. 2016 Jun 13;5(6):e003725. doi: 10.1161/JAHA.116.003725.
10
Resolution of Extensive Coronary Thrombosis under Rivaroxaban Treatment.利伐沙班治疗下广泛冠状动脉血栓形成的消退
Arq Bras Cardiol. 2015 Dec;105(6):642-6. doi: 10.5935/abc.20150052.